Chief Business Officer
Galera Therapeutics Inc.
United States of America
Mr. Fratamico is a registered pharmacist with over 25 years of experience in the pharmaceutical industry and has been our Chief Business Officer since January 2017. Prior to joining Galera, Mr. Fratamico served as Chief Business Officer of Vitae Pharmaceuticals until its sale to Allergan. Prior to Vitae Pharmaceuticals, he has held similar executive roles with a number of biotechnology companies leading their business development efforts, including facilitating the sales of Gemin X Pharmaceuticals and MGI Pharma. In addition to being responsible for numerous licensing transactions and acquisitions, he also directed corporate strategy and managed external corporate communications. He also served in several senior marketing, product planning and new product development positions. Mr. Fratamico earned a bachelor’s degree in pharmacy from the Philadelphia College of Pharmacy and Science and an M.B.A. from Drexel University.
Host defense mechanisms,LPS effects on neurotransmitters